Microbot Medical Inc. (MBOT:NASDAQ) closed at $0.942 on October 22, 2026, up 0.19% on the day. The stock trades 67.1% below its 52-week high of $2.86 and 1.3% above its 52-week low of $0.930. Over the past year, it lost 62.5%. Microbot Medical Inc. is part of the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)).
In 252 trading sessions since October 22, 2025, MBOT closed higher on 89 days (35%). Its best day was February 24, 2026 (+23.90%) and its worst was May 14, 2026 (-14.75%). The stock moved 10% or more in a single session 8 times. It opened at least 5% above the previous day's high 2 times.
Microbot Medical Inc., a medical device company, engages in the research, design, development, and commercialization of micro-robotics medical technologies. Its ViRob and TipCAT platforms consist of micro-robotic technologies, from which the company is developing its product candidates, including the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and normal pressure hydrocephalus (NPH); and a self-propelling, semi-disposable endoscope that is being developed initially for use in colonoscopy procedures. The company was founded in 2010 and is based in Yokneam, Israel.
Find more stocks like MBOT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.